SEC Form 4 · accession 0001179110-17-001818
RIGEL PHARMACEUTICALS INC · RIGL
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Anne-Marie Duliege
Officer — Chief Medical Officer
Period of report
Feb 2, 2017
Accepted (ET)
Feb 6, 2017 · 7:25 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001034842
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy)F1 | $2.11 | Feb 2, 2017 | A | 150,000 | A | — | Feb 2, 2027 | Common Stock | 150,000 | 150,000 | D |
Explanation of responses
- F1The shares vest monthly over four (4) years from January 1, 2017.